BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25872329)

  • 21. Endometriosis-associated ovarian malignancy: a retrospective analysis of presentation, treatment, and outcome.
    Garrett LA; Growdon WB; Goodman A; Boruta DM; Schorge JO; del Carmen MG
    J Reprod Med; 2013; 58(11-12):469-76. PubMed ID: 24568040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemistry expression of targeted therapies biomarkers in ovarian clear cell and endometrioid carcinomas (type I) and endometriosis.
    Barreta A; Sarian LO; Ferracini AC; Costa LBE; Mazzola PG; de Angelo Andrade L; Derchain S
    Hum Pathol; 2019 Mar; 85():72-81. PubMed ID: 30447298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovarian endometriosis associated with ovarian cancer and endometrial-endocervical polyps.
    Kontoravdis A; Augoulea A; Lambrinoudaki I; Christodoulakos G; Tzortziotis D; Grammatikakis I; Kontoravdis N; Creatsas G
    J Obstet Gynaecol Res; 2007 Jun; 33(3):294-8. PubMed ID: 17578358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012.
    Kim SI; Lim MC; Lim J; Won YJ; Seo SS; Kang S; Park SY
    J Gynecol Oncol; 2016 Jan; 27(1):e5. PubMed ID: 26463436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types.
    Stern RC; Dash R; Bentley RC; Snyder MJ; Haney AF; Robboy SJ
    Int J Gynecol Pathol; 2001 Apr; 20(2):133-9. PubMed ID: 11293158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis.
    Chene G; Ouellet V; Rahimi K; Barres V; Provencher D; Mes-Masson AM
    Int J Gynaecol Obstet; 2015 Jul; 130(1):27-30. PubMed ID: 25912412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of endometrioid and clear-cell ovarian cancer in histological proven endometriosis: the ENOCA population-based cohort study.
    Hermens M; van Altena AM; Nieboer TE; Schoot BC; van Vliet HAAM; Siebers AG; Bekkers RLM
    Am J Obstet Gynecol; 2020 Jul; 223(1):107.e1-107.e11. PubMed ID: 31981507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological characteristics of ovarian carcinomas associated with endometriosis.
    Kondi-Pafiti A; Papakonstantinou E; Iavazzo C; Grigoriadis C; Salakos N; Gregoriou O
    Arch Gynecol Obstet; 2012 Feb; 285(2):479-83. PubMed ID: 21717140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endometrioid adenocarcinoma of the ovary and endometriosis.
    Valenzuela P; Ramos P; Redondo S; Cabrera Y; Alvarez I; Ruiz A
    Eur J Obstet Gynecol Reprod Biol; 2007 Sep; 134(1):83-6. PubMed ID: 16844279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical discussion of the relationship between endometriosis and epithelial ovarian cancer].
    Zhang Y; Huang H; Lian L
    Zhonghua Fu Chan Ke Za Zhi; 1999 Sep; 34(9):544-6. PubMed ID: 11360640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors.
    Nagle CM; Olsen CM; Webb PM; Jordan SJ; Whiteman DC; Green AC; ;
    Eur J Cancer; 2008 Nov; 44(16):2477-84. PubMed ID: 18707869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary.
    Davis M; Rauh-Hain JA; Andrade C; Boruta DM; Schorge JO; Horowitz NS; May T; del Carmen MG
    Gynecol Oncol; 2014 Mar; 132(3):760-6. PubMed ID: 24440832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endometriosis and the development of malignant tumours of the pelvis. A review of literature.
    Van Gorp T; Amant F; Neven P; Vergote I; Moerman P
    Best Pract Res Clin Obstet Gynaecol; 2004 Apr; 18(2):349-71. PubMed ID: 15157647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The malignant transformation of endometriosis: Is there a left lateral predisposition of ovarian clear cell and endometrioid carcinomas?
    McMullan JC; Graham MJ; Craig EF; McCluggage WG; Hunter DH; Feeney L
    Eur J Surg Oncol; 2024 Jun; 50(6):108247. PubMed ID: 38522332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unraveling the two entities of endometrioid ovarian cancer: a single center clinical experience.
    Mangili G; Bergamini A; Taccagni G; Gentile C; Panina P; ViganĂ² P; Candiani M
    Gynecol Oncol; 2012 Sep; 126(3):403-7. PubMed ID: 22609111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathology of Endometrioid and Clear Cell Carcinoma of the Ovary.
    Fadare O; Parkash V
    Surg Pathol Clin; 2019 Jun; 12(2):529-564. PubMed ID: 31097114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endometriosis-associated Ovarian Cancers.
    Anglesio MS; Yong PJ
    Clin Obstet Gynecol; 2017 Dec; 60(4):711-727. PubMed ID: 28990985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dichotomy in the histogenesis of endometriosis-associated ovarian cancer: clear cell-type versus endometrioid-type adenocarcinoma.
    Kajihara H; Yamada Y; Shigetomi H; Higashiura Y; Kobayashi H
    Int J Gynecol Pathol; 2012 Jul; 31(4):304-12. PubMed ID: 22653342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Risk factors of endometriosis associated ovarian carcinoma in women aged 45 years and older].
    He ZX; Wang S; Li ZF; Zhu L; Leng JH; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2017 May; 52(5):314-319. PubMed ID: 28545269
    [No Abstract]   [Full Text] [Related]  

  • 40. Endometriosis-associated epithelial ovarian cancer is a more complicated disease than we suspected before.
    Yang ST; Chang WH; Lee NR; Lai WA; Shen SH; Lee WL; Wang PH
    Taiwan J Obstet Gynecol; 2021 Nov; 60(6):1112-1115. PubMed ID: 34794748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.